Advertisement
News
Subscribe to MDT Magazine News

Long-term Safety and Effectiveness of Bronchial Thermoplasty Demonstrated in Treating Severe Asthma

May 16, 2011 9:32 am | by Boston Scientific | Comments

Five-year data from RISA Trial presented at ATS adds to clinical evidence showing long-term safety of Boston Scientific's Alair® Bronchial Thermoplasty System

TOPICS:

FDA News & Notes - Week of May 16, 2011

May 16, 2011 9:32 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., May 16, 2011 /PRNewswire-USNewswire/ -- Science, public health, and regulatory highlights for this week from the U.S. Food and Drug Administration. Information in this document is designed for credentialed journalists. Release dates and times for items are current as...

TOPICS:

Holzer Holzer & Fistel, LLC Announces That It Has Filed a Class Action Lawsuit on Behalf of Community Health Systems, Inc. Shareholders

May 16, 2011 8:45 am | by The Associated Press | Comments

Holzer Holzer & Fistel, LLC announces that it has filed a class action lawsuit in the United States District Court for the Middle District of Tennessee on behalf of purchasers of Community Health Systems, Inc. ("Community Health" or the "Company") (NYSE: CYH) common stock who purchased...

Advertisement

Augmenix sells minority stake to Varian Medical for $15M

May 16, 2011 8:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Waltham biotech Augmenix Inc. has inked a deal with California med tech giant Varian Medical Systems Inc. in which Varian will pay $15 million for a minority stake in Augmenix.

TOPICS:

Dune Medical's breast cancer device moves closer to market

May 16, 2011 8:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Dune Medical Devices Inc. says it has won an expedited review from the U.S. Food and Drug Administration (FDA) for its experimental device designed to improve the accuracy of breast cancer tumor removal surgery.

TOPICS:

BridgePoint Medical Announced 510(k) Clearance for an Expanded Indication to Treat Coronary Chronic Total Occlusions

May 16, 2011 8:35 am | by Bio-Medicine.Org | Comments

MINNEAPOLIS, May 16, 2011 /- BridgePoint Medical, Inc., a Minnesota-based medical device company, has announced that they have received clearance of an expanded indication for the CrossBoss™ Catheter and Stingray™ System from the FDA.  The expanded indication includes the...

TOPICS:

Abaxis Receives Presidential "E" Award for Exports

May 16, 2011 8:34 am | by Bio-Medicine.Org | Comments

UNION CITY, Calif., May 16, 2011 /- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today announced the Company was awarded the Presidential "E" Award for Exports by U.S. Department of Commerce Secretary Gary Locke at the...

TOPICS:

Perrigo Announces FDA Final Approval for Ranitidine 150 - Generic Equivalent to Zantac 150®

May 16, 2011 8:33 am | by Bio-Medicine.Org | Comments

ALLEGAN, Mich., May 16, 2011 /- Perrigo Company (Nasdaq: PRGO ; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for over-the-counter (OTC) Ranitidine 150 (regular and cool mint), a generic...

TOPICS:
Advertisement

More Than 11,000 Manufacturers Expected to Attend EASTEC 2011 This Week

May 16, 2011 6:37 am | by Society of Manufacturing Engineers | Comments

DEARBORN, Mich., May 16, 2011 — EASTEC 2011 opens tomorrow for a three-day run and is expected to attract manufacturers from the entire East Coast. The event features 500 exhibitors, including industry leaders Mitsubishi, Citizen Machinery America, Compumachine and Brooks...

Watson Launches Generic AMRIX®

May 16, 2011 6:35 am | by Bio-Medicine.Org | Comments

PARSIPPANY, N.J., May 16, 2011 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ) today confirmed that its subsidiary, Watson Pharma, Inc., has launched an authorized generic version of AMRIX® (Cyclobenzaprine Hydrochloride Extended-Release Capsules) 15 mg and 30 mg, as part of an...

TOPICS:

New Mexico Software Announces 2011 First Quarter Financial Results

May 16, 2011 6:35 am | by Bio-Medicine.Org | Comments

ALBUQUERQUE, N.M., May 16, 2011 /- New Mexico Software, Inc. (OTCBB: NMXC) announced today the company's financial results for the first quarter of 2011. Revenue for the first quarter ended March 31, 2011 was $936,000, an increase of 4% compared to $903,000 reported in the same quarter a...

TOPICS:

Microbix Biosystems second-quarter loss grows slightly as sales fall 16 per cent

May 16, 2011 5:45 am | by The Associated Press | Comments

Biotechnology firm Microbix Biosystems Inc. (TSX:MBX) second-quarter net loss increases slightly to $1.4 million from year-ago $1.3 million; revenues down four per cent to $1.76 million as sales slide 16 per cent on one-time reduction in purchases by large customer. Says issues have arisen in...

MoMelan gets mo' money in $2.9M first round

May 16, 2011 5:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Cambridge medical device company MoMelan Technologies Inc. has raised $2.9 million of a planned $5 million funding round – the first institutional round for the company, which is making a device designed to stretch skin to improve the cost, time and patient experience of skin graft procedures.

PerkinElmer buys Labtronics

May 16, 2011 5:37 am | by Mass High Tech: The Journal of New England Technology | Comments

PerkinElmer Inc. continued its recent buying spree today with the announcement that it has acquired Ontario, Canada-based Labtronics Inc., a health IT company that makes electronic laboratory notebooks (ELN) – software designed to replace paper lab notebooks.

BAETA Corp Initiates Clinical Trial at NYU School of Medicine to Measure Efficacy of Pain Recording Device

May 16, 2011 5:37 am | by Bio-Medicine.Org | Comments

FORT LEE, N.J., May 16, 2011 /- BAETA Corp. (OTCBB: BAEA) announced today that the NYU School of Medicine will conduct a clinical trial to measure the efficacy of the Company's "MyHealthTrends for Pain" handheld device during intra-operative, pre- and post-surgical periods. This trial...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading